Praxis Precision Medicines
PRAX
278.02
-2.12
-0.76%
Praxis Precision Medicines
US · PRAX
#1645 by market cap
Listed 2020
278.02
-2.12
-0.76%
Live - 5344 symbols - heartbeat 52s ago
· 2026-10-08 04:00
Pre-market
278.02
0.00%
After-hours
280.00
+0.71%
Overnight
276.72
-0.47%
- Market cap
- 7.76B
- P/E (TTM)i
- -21.45
- P/Bi
- 5.79
- EPSi
- -13.48
- Div yieldi
- 0.00%
- 52W posi
- 66%
Reader sentiment
Are you bullish or bearish on PRAX?
Anonymous reader poll. Unscientific, not investment advice.
Analyst consensus 13 analysts
Buy
Avg price target
718.69 +158.5%
Price target rangecurrent 278.02
Low462.00
Avg718.69
High1,201.00
Buy 100%
Hold 0%
Sell 0%
Recent ratings (25)
| Date | Firm | Analyst | Rating | Target |
|---|---|---|---|---|
| 2026-10-05 | H.C. Wainwright | -- | BUY | 1,201.00 |
| 2026-10-01 | JonesTrading | -- | BUY | 534.00 |
| 2026-09-24 | Needham | -- | BUY | 582.00 |
| 2026-09-24 | H.C. Wainwright | -- | BUY | 1,201.00 |
| 2026-08-21 | Goldman Sachs | -- | BUY | 575.00 |
| 2026-08-20 | Goldman Sachs | -- | BUY | 575.00 |
| 2026-08-17 | Raymond James | -- | BUY | 945.00 |
| 2026-08-17 | Oppenheimer | -- | BUY | 650.00 |
| 2026-08-10 | H.C. Wainwright | -- | BUY | 1,201.00 |
| 2026-08-08 | LifeSci Capital | -- | BUY | 754.00 |
| 2026-08-07 | JonesTrading | -- | BUY | 441.00 |
| 2026-08-07 | Piper Sandler | -- | BUY | 1,200.00 |
| 2026-08-07 | Truist Financial | -- | BUY | 616.00 |
| 2026-08-07 | Baird | -- | BUY | 514.00 |
| 2026-08-07 | H.C. Wainwright | -- | BUY | 1,201.00 |
| 2026-08-06 | TD Cowen | -- | BUY | 510.00 |
| 2026-08-06 | LifeSci Capital | -- | BUY | 754.00 |
| 2026-08-06 | Needham | -- | BUY | 582.00 |
| 2026-08-06 | Goldman Sachs | -- | BUY | 470.00 |
| 2026-08-06 | Guggenheim | -- | BUY | 800.00 |
| 2026-08-06 | RBC Capital | -- | BUY | 462.00 |
| 2026-07-21 | LifeSci Capital | -- | BUY | 719.00 |
| 2026-07-17 | Goldman Sachs | -- | BUY | 447.00 |
| 2026-07-13 | Piper Sandler | -- | BUY | 1,200.00 |
| 2026-07-13 | Goldman Sachs | -- | BUY | 447.00 |
Quant vs Street three independent views, side by side
Momentum strategy signal
Sell
Analyst consensus
Buy
Signals diverge - worth digging into why.
Not investment advice. The factor grade ranks this stock on fundamentals against StockVane's covered universe; the momentum strategy signal is a rules-based backtest, not a recommendation; analyst consensus reflects sell-side coverage. The three use different methods and can reasonably disagree.
Price target trend monthly average, last 3 years
Earnings history price reaction on the day
| Period | Report date | Session | Options expected | Actual move |
|---|---|---|---|---|
| 2026/Q2 | 2026-08-06 | -- | ±9.81% | +15.95% (beat) |
| 2026/Q1 | 2026-05-07 | -- | ±11.21% | -1.42% (in line) |
| 2025/Q4 | 2026-02-19 | -- | ±7.30% | +0.81% (in line) |
| 2025/Q2 | 2025-08-04 | -- | ±37.17% | -5.55% (in line) |
| 2024/Q3 | 2024-11-06 | -- | ±23.07% | -1.18% (in line) |
| 2024/Q2 | 2024-08-13 | -- | ±21.97% | +0.81% (in line) |
| 2024/Q1 | 2024-05-13 | -- | ±16.42% | -7.36% (in line) |
| 2022/Q1 | 2022-05-09 | -- | ±26.70% | -8.54% (in line) |
| 2021/Q4 | 2022-02-28 | -- | -- | -1.73% |
| 2021/Q3 | 2021-11-03 | -- | ±15.90% | +1.24% (in line) |
| 2020/Q4 | 2021-03-17 | -- | -- | +2.56% |
"Options expected" is the pre-earnings options market's implied move (a straddle-style estimate), shown next to what actually happened.
Quote time 2026-10-08 04:00:01 · For reference only, not investment advice and not tailored to your situation.